Next Article in Journal
Do Patient-Reported Upper-Body Symptoms Predict Breast Cancer-Related Lymphoedema: Results from a Population-Based, Longitudinal Breast Cancer Cohort Study
Next Article in Special Issue
Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients with No Progression and with No More than Five Residual Metastatic Lesions Following First-Line Systemic Therapy: A Retrospective Analysis
Previous Article in Journal
An Optimal Artificial Intelligence System for Real-Time Endoscopic Prediction of Invasion Depth in Early Gastric Cancer
Previous Article in Special Issue
Oncological Outcomes for Patients Harboring Positive Surgical Margins Following Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Retrospective Multicentric Study on Behalf of the YAU Urothelial Group
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Diamant et al. Effectiveness of Early Radical Cystectomy for High-Risk Non-Muscle Invasive Bladder Cancer. Cancers 2022, 14, 3797

1
Sorbonne Université, Department of Urology, GRC n°5 Predictive Onco-Urology, AP-HP, Pitié-Salpêtrière Hospital, 75013 Paris, France
2
Department of Urology, CHU-Institut Universitaire du Cancer-Oncopôle, 31000 Toulouse, France
3
Department of Urology, University Hospital Henri Mondor, APHP, UPEC, 94000 Créteil, France
*
Author to whom correspondence should be addressed.
Cancers 2022, 14(23), 6001; https://doi.org/10.3390/cancers14236001
Submission received: 9 October 2022 / Accepted: 31 October 2022 / Published: 5 December 2022
(This article belongs to the Special Issue Advance and New Insights in Bladder Cancer)
In the original article [1], there were mistakes in Figure 1, Figure 2, Figure 3, Figure 6, Figure 7 and Figure 8 as published. These survival curves are those with T0 set at the time of initial transurethral resection of the bladder tumor, while we chose to publish the results of survival analyses with T0 set at the time of early radical cystectomy (eRC) to report on the specific effect of this procedure for high-risk non-muscle invasive bladder cancer. All the results in the main text are correct with T0 set at the time of eRC, but the survival curves do not match these results. The corrected Figure 1, Figure 2, Figure 3, Figure 6, Figure 7 and Figure 8 appear below. The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. The original article has been updated.

Reference

  1. Diamant, E.; Roumiguié, M.; Ingels, A.; Parra, J.; Vordos, D.; Bajeot, A.-S.; Chartier-Kastler, E.; Soulié, M.; de la Taille, A.; Rouprêt, M.; et al. Effectiveness of Early Radical Cystectomy for High-Risk Non-Muscle Invasive Bladder Cancer. Cancers 2022, 14, 3797. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Kaplan–Meier curve that analyses the RFS of included patients treated with eRC for HR-NMIBC.
Figure 1. Kaplan–Meier curve that analyses the RFS of included patients treated with eRC for HR-NMIBC.
Cancers 14 06001 g001
Figure 2. Kaplan–Meier curve that analyses the CSS of included patients treated with eRC for HR-NMIBC.
Figure 2. Kaplan–Meier curve that analyses the CSS of included patients treated with eRC for HR-NMIBC.
Cancers 14 06001 g002
Figure 3. Kaplan–Meier curve that analyses the OS of included patients treated with eRC for HR-NMIBC.
Figure 3. Kaplan–Meier curve that analyses the OS of included patients treated with eRC for HR-NMIBC.
Cancers 14 06001 g003
Figure 6. Inverse probability of treatment weighting (IPTW)-adjusted Kaplan–Meier curves that compare the RFS of included patients treated with upfront or delayed eRC for HR-NMIBC.
Figure 6. Inverse probability of treatment weighting (IPTW)-adjusted Kaplan–Meier curves that compare the RFS of included patients treated with upfront or delayed eRC for HR-NMIBC.
Cancers 14 06001 g006
Figure 7. Inverse probability of treatment weighting (IPTW)-adjusted Kaplan–Meier curves that compare the CSS of included patients treated with upfront or delayed eRC for HR-NMIBC.
Figure 7. Inverse probability of treatment weighting (IPTW)-adjusted Kaplan–Meier curves that compare the CSS of included patients treated with upfront or delayed eRC for HR-NMIBC.
Cancers 14 06001 g007
Figure 8. Inverse probability of treatment weighting (IPTW)-adjusted Kaplan–Meier curves that compare the OS of included patients treated with upfront or delayed eRC for HR-NMIBC.
Figure 8. Inverse probability of treatment weighting (IPTW)-adjusted Kaplan–Meier curves that compare the OS of included patients treated with upfront or delayed eRC for HR-NMIBC.
Cancers 14 06001 g008
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Diamant, E.; Roumiguié, M.; Ingels, A.; Parra, J.; Vordos, D.; Bajeot, A.-S.; Chartier-Kastler, E.; Soulié, M.; de la Taille, A.; Rouprêt, M.; et al. Correction: Diamant et al. Effectiveness of Early Radical Cystectomy for High-Risk Non-Muscle Invasive Bladder Cancer. Cancers 2022, 14, 3797. Cancers 2022, 14, 6001. https://doi.org/10.3390/cancers14236001

AMA Style

Diamant E, Roumiguié M, Ingels A, Parra J, Vordos D, Bajeot A-S, Chartier-Kastler E, Soulié M, de la Taille A, Rouprêt M, et al. Correction: Diamant et al. Effectiveness of Early Radical Cystectomy for High-Risk Non-Muscle Invasive Bladder Cancer. Cancers 2022, 14, 3797. Cancers. 2022; 14(23):6001. https://doi.org/10.3390/cancers14236001

Chicago/Turabian Style

Diamant, Elliott, Mathieu Roumiguié, Alexandre Ingels, Jérôme Parra, Dimitri Vordos, Anne-Sophie Bajeot, Emmanuel Chartier-Kastler, Michel Soulié, Alexandre de la Taille, Morgan Rouprêt, and et al. 2022. "Correction: Diamant et al. Effectiveness of Early Radical Cystectomy for High-Risk Non-Muscle Invasive Bladder Cancer. Cancers 2022, 14, 3797" Cancers 14, no. 23: 6001. https://doi.org/10.3390/cancers14236001

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop